Bristol-Myers Squibb

Is Tranzyme A Takeover Target For Bristol-Myers Squibb?
Seeking Alpha
Mon, 01/14/13 - 12:28 pm
M&A
Bristol-Myers Squibb
Tranzyme
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
JPMorgan Healthcare Conference Highlights: Bristol-Myers Squibb
Motley Fool
Wed, 01/9/13 - 10:01 am
JPMHC 2013
Bristol-Myers Squibb
Encouraging News for Tranzyme Pharma
Yahoo/Zacks.com
Mon, 01/7/13 - 07:03 pm
Bristol-Myers Squibb
Tranzyme
R&D
Bristol-Myers May Sell Experimental Migraine Drug
Bloomberg
Mon, 01/7/13 - 07:00 pm
migraines
Bristol-Myers Squibb
BMS-927711
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals
Tranzyme Partners with Bristol-Myers, Lilly Fights Patent Cliff: Healthcare Business Recap
Wall Street Cheat Sheet
Sat, 01/5/13 - 10:40 am
Tranzyme
Bristol-Myers Squibb
partnerships
Eli Lilly
patent
Healthcare
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wed, 01/2/13 - 11:47 am
Achillion
Abbott Labs
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Vertex Pharmaceuticals
The Top Pharma Acquisitions of 2012
The Motley Fool
Mon, 12/31/12 - 04:35 pm
Pharma
M&A
Bristol-Myers Squibb
AstraZeneca
GlaxoSmithKline
FDA clears anticlotting drug Eliquis
Yahoo/AP
Fri, 12/28/12 - 09:28 pm
FDA
Eliquis
Pfizer
Bristol-Myers Squibb
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
Bristol-Myers, Pfizer's Eliquis approved in Japan
Yahoo/AP
Wed, 12/26/12 - 12:02 pm
Pfizer
Japan
Bristol-Myers Squibb
9 Pharmaceutical Stocks to Sell Now
InvestorPlace
Sat, 12/22/12 - 12:56 pm
Corcept Therapeutics
Cornerstone Therapeutics
Bristol-Myers Squibb
ViroPharma
MAP Pharmaceuticals
Hi-Tech Pharmacal
GSK
Hospira
Teva Pharmaceuticals
Oncolytics Biotech: What Is All The Excitement About?
Seeking Alpha
Tue, 12/18/12 - 12:41 pm
Oncolytics
GenVec
Amgen
Bristol-Myers Squibb
Pfizer
Eli Lilly
YM BioSciences
ONYX Pharmaceuticals
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Mon, 12/17/12 - 09:31 am
FDA
drug approvals
Ariad Pharmaceuticals
Novartis
Dendreon
Medivation
Bayer
ONYX Pharmaceuticals
Otsuka
Bristol-Myers Squibb
Big Yields in Drug Land
Motley Fool
Sat, 12/15/12 - 12:53 pm
Pfizer
Merck
JNJ
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
PDL Biopharma
Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts
Seeking Alpha
Thu, 12/13/12 - 04:23 pm
Synta Pharmaceuticals
Ariad Pharma
GSK
Bristol-Myers Squibb
The Medicines Co., Bristol-Myers sign global alliance pact for Recothrom
Yahoo/Fly on the Wall
Wed, 12/12/12 - 08:13 am
Bristol-Myers Squibb
Recothrom
Medicines Company
recombinant thrombin
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
diabetes
Bayer
Sanofi
Novo Nordisk
Abbott Labs
Bristol-Myers Squibb

Pages